272 related articles for article (PubMed ID: 17848490)
21. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
[TBL] [Abstract][Full Text] [Related]
22. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
Peterson LR
Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of community-acquired pneumonia--treatment].
Andersen LV; Brock B; Jakobsen P; Nielsen LP
Ugeskr Laeger; 2008 Jan; 170(3):127-30. PubMed ID: 18208726
[TBL] [Abstract][Full Text] [Related]
24. New susceptibility breakpoints in antimicrobial resistance rates of invasive pneumococcal strains.
Wolkers PC; Mantese OC; Paula Ad; Almeida VV; Aguiar PA; Alvares JR; Almeida SC; Brandileone MC
J Pediatr (Rio J); 2009; 85(5):421-5. PubMed ID: 19830357
[TBL] [Abstract][Full Text] [Related]
25. [The drug susceptibility of penicillin-resistant Streptococcus pneumoniae].
Koiuszko S; Białucha A; Gospodarek E
Med Dosw Mikrobiol; 2007; 59(4):293-300. PubMed ID: 18416121
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of ampicillin and combination of penicillin and chloramphenicol in the treatment of pneumonias: randomized controlled trial.
Deivanayagam N; Nedunchelian K; Ashok TP; Mala N; Sheela D; Rathnam SR
Indian Pediatr; 1996 Oct; 33(10):813-6. PubMed ID: 9057377
[TBL] [Abstract][Full Text] [Related]
27. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.
Chang NN; Murray CK; Houck PM; Bratzler DW; Greenway C; Guglielmo BJ
Pharmacotherapy; 2005 Jan; 25(1):59-66. PubMed ID: 15767221
[TBL] [Abstract][Full Text] [Related]
28. Pneumococcal endocarditis in children: a nationwide survey in Japan.
Ishiwada N; Niwa K; Tateno S; Yoshinaga M; Terai M; Nakazawa M
Int J Cardiol; 2008 Jan; 123(3):298-301. PubMed ID: 17383029
[TBL] [Abstract][Full Text] [Related]
29. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
30. Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network.
Shah AS; Knoll MD; Sharma PR; Moisi JC; Kulkarni P; Lalitha MK; Steinhoff M; Thomas K
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S123-8. PubMed ID: 19191607
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
[TBL] [Abstract][Full Text] [Related]
32. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical significance of community-acquired penicillin-resistant pneumococcal pneumonia in Thailand.
Sangthawan P; Chantaratchada S; Chanthadisai N; Wattanathum A
Respirology; 2003 Jun; 8(2):208-12. PubMed ID: 12753538
[TBL] [Abstract][Full Text] [Related]
34. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Asghar R; Banajeh S; Egas J; Hibberd P; Iqbal I; Katep-Bwalya M; Kundi Z; Law P; MacLeod W; Maulen-Radovan I; Mino G; Saha S; Sempertegui F; Simon J; Santosham M; Singhi S; Thea DM; Qazi S;
BMJ; 2008 Jan; 336(7635):80-4. PubMed ID: 18182412
[TBL] [Abstract][Full Text] [Related]
35. Does penicillin remain the drug of choice for pneumococcal pneumonia in view of emerging in vitro resistance?
Chiou CC
Clin Infect Dis; 2006 Jan; 42(2):234-7. PubMed ID: 16355334
[No Abstract] [Full Text] [Related]
36. Nasopharyngeal Streptococcus pneumoniae among under-five year old children at the Moi Teaching and Referral Hospital, Eldoret, Kenya.
Nyandiko WM; Greenberg D; Shany E; Yiannoutsos CT; Musick B; Mwangi AW
East Afr Med J; 2007 Apr; 84(4):156-62. PubMed ID: 17894249
[TBL] [Abstract][Full Text] [Related]
37. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
Falade AG; Lagunju IA; Bakare RA; Odekanmi AA; Adegbola RA
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S190-6. PubMed ID: 19191615
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of pneumonia caused by penicillin resistant and sensitive Streptococcus pneumoniae in Japan.
Yanagihara K; Otsu Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Tomono K; Kadota J; Tashiro T; Kohno S
Intern Med; 2004 Nov; 43(11):1029-33. PubMed ID: 15609696
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population.
Wexler ID; Knoll S; Picard E; Villa Y; Shoseyov D; Engelhard D; Kerem E
Pediatr Pulmonol; 2006 Aug; 41(8):726-34. PubMed ID: 16779839
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
